DraftKings Stock Has 24% Upside, According to 1 Wall Street Analyst
Published
Will these catalysts be enough to support the stock's high valuation?
Full ArticlePublished
Will these catalysts be enough to support the stock's high valuation?
Full ArticleBiotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.
One analyst expects Disney's free cash flow to soar.